Business Wire

  1. Thermo Fisher Scientific Launches Thermo Scientific Glacios 3 Cryo-TEM 3/31/2026

    Thermo Fisher Scientific, the world leader in serving science, today introduces a next-generation cryogenic transmission electron microscope (cryo-TEM) designed to help scientists understand structural biology with greater clarity — now accessible in more lab environments than ever before.

  2. Ataraxis AI Launches Ataraxis Breast CTX, The First Predictive AI Test Estimating Individualized Chemotherapy Benefit In Breast Cancer 3/30/2026

    Ataraxis AI, a frontier artificial intelligence (AI) research lab developing AI-powered tools for oncology, today announced Ataraxis Breast CTX, a new predictive capability within its Ataraxis Breast platform, designed to help estimate individualized chemotherapy benefit in breast cancer patients.

  3. StarLIMS To Acquire The MODA Platform From Lonza, Expanding Deeper Into Manufacturing Operations & Quality Control 3/25/2026

    StarLIMS has agreed to acquire the MODA Platform, a trusted solution for manufacturing quality assurance and control in regulated environments. The transaction is expected to close in Q2 2026, subject to customary closing conditions.

  4. CorePlus And Ibex Expand Partnership With Clinical Deployment Of AI-Powered Diagnostics For TURP 3/25/2026

    CorePlus Servicios Clínicos y Patológicos, LLC (CorePlus), a high-complexity CLIA-certified laboratory and global leader in digital transformation, and Ibex Medical Analytics (Ibex), a pioneer in AI-powered cancer diagnostics, today announced the first clinical deployment of Ibex Prostate for Transurethral Resection of the Prostate (TURP), an AI solution for rapid, high-volume diagnostic support.

  5. Countable Labs Brings Innovative, Single-Molecule, Counting-Based PCR To European Markets With CE Mark Clearance 3/25/2026

    Countable Labs, the developer of Countable PCR, the leading PCR innovation transforming how science measures biology, achieved CE marking for its Countable 4 Platform, a single-molecule PCR instrument for molecular quantification featuring Countable PCR technology.

  6. Integrated DNA Technologies Expands Into Clinical Diagnostics With First In Vitro Diagnostic 3/23/2026

    Global genomics leader Integrated DNA Technologies (IDT) today announced the launch of Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx in vitro diagnostic (IVD) offerings.

  7. Agilent Showcases Advances In Precision Oncology And Digital Pathology At USCAP 2026 3/19/2026

    Agilent Technologies Inc. today announced it will feature its latest advances in precision oncology and digital pathology workflows at the 2026 United States and Canadian Academy of Pathology (USCAP) Annual Meeting, taking place March 21-26 in San Antonio, Texas.

  8. Ibex Expands U.S. Footprint With HNL Lab Medicine Partnership To Deploy Clinical-Grade AI To Support Cancer Diagnostics 3/19/2026

    Ibex Medical Analytics (Ibex), a leader in clinical-grade AI-powered pathology, today announced a strategic collaboration with HNL Lab Medicine, a leading multi-regional medical laboratory in the United States.

  9. Guardant Health Launches Shield Multi-Cancer Detection (MCD) Test In Multiple Markets In Asia With Manulife Partnership 3/16/2026

    Guardant Health, Inc. a leading precision oncology company, today announced the launch of the Shield multi-cancer detection (MCD) laboratory developed test (LDT) in multiple markets in Asia.

  10. RevnaBio Secures Triple International Laboratory Accreditation To Expand Precision Medicine And Clinical Research Infrastructure In Africa 3/16/2026

    RevnaBio today announced that it has received triple accreditation from the American Association for Laboratory Accreditation (A2LA), validating its laboratory and biobanking operations under three internationally recognized standards: ISO 15189 for medical laboratories, ISO 20387 for biobanking, and ISO/IEC 17043 for proficiency testing providers.